Evidence map›Paper›PMID 24223212›Full record

ArticlePloS one2013

Vaginal pH and microbicidal lactic acid when lactobacilli dominate the microbiota.

Deirdre E O'Hanlon, Thomas R Moench, Richard A Cone

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05723601 (Addressing Preference as a Patient-centered Outcome to Prevent Recurrent Urinary Tract Infection), which is not on this map. Cited by 319 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
319citing papers in PubMed, 4 pooled it
14.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05723601 phase4active not recruitingnot on this mapstarted 2024, after this paper: background citation

Addressing Preference as a Patient-centered Outcome to Prevent Recurrent Urinary Tract Infection (rUTI) in Post-menopausal Women: a Cross-over Randomized Controlled Trial

TypeinterventionalSponsorWake Forest University Health SciencesRan2024 to 2027Enrolled21ConditionsRecurrent Urinary Tract InfectionArmsEstradiol vaginal cream, Estradiol Vaginal Tablet
3 · Its place in the literature

Who cites it

319 citing papers in PubMed, 4 syntheses or guidelines pooled it, 541 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. The Effect of Exogenous Sex Steroids on the Vaginal Microbiota: A Systematic Review.Frontiers in cellular and infection microbiology · 2021
    Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Review
  10. Article
  11. The redefined identity ofJournal of bacteriology · 2026
    Review
  12. Review
  13. Article
  14. Complement protein concentrations and activity in human cervical mucus.bioRxiv : the preprint server for biology · 2026
    Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

259 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Deirdre E O'HanlonThomas C. Jenkins Department of Biophysics, Johns Hopkins University, Baltimore, Maryland, United States of America.
Thomas R Moench
Richard A Cone
Johns Hopkins University · USReProtect (United States) · US

Funding

Vaginal mAB Delivery SystemsU19AI096398 · NIAID · BOSTON UNIVERSITY MEDICAL CAMPUS · PI ANDERSON, DEBORAH J, MOENCH, THOMAS RAY · 2011 to 2016
$15.0M
Supplement to grant: Development of Dendrimer and Combination MicrobicidesU19AI060598 · NIAID · STARPHARMA, LTD · PI PAULL, JEREMY · 2004 to 2009
$6.9M
UPTAKE OF IG BY VAGINAL EPITHELIAL CELLSP01AI045967 · NIAID · JOHNS HOPKINS UNIVERSITY · PI CONE, RICHARD A · 1999 to 2003
$3.4M
Duet cervical barrier device for maximizing protective efficacy of microbicidesU01AI066726 · NIAID · JOHNS HOPKINS UNIVERSITY · PI CONE, RICHARD · 2005 to 2009
$2.0M
NIAID NIH HHS AI096398NIAID NIH HHS AI45967NIAID NIH HHS AI60598NIAID NIH HHS AI66726NIAID NIH HHS P01 AI045967NIAID NIH HHS U01 AI066726NIAID NIH HHS U19 AI060598NIAID NIH HHS U19 AI096398
6 · The paper itself

Abstract

Lactic acid at sufficiently acidic pH is a potent microbicide, and lactic acid produced by vaginal lactobacilli may help protect against reproductive tract infections. However, previous observations likely underestimated healthy vaginal acidity and total lactate concentration since they failed to exclude women without a lactobacillus-dominated vaginal microbiota, and also did not account for the high carbon dioxide, low oxygen environment of the vagina. Fifty-six women with low (0-3) Nugent scores (indicating a lactobacillus-dominated vaginal microbiota) and no symptoms of reproductive tract disease or infection, provided a total of 64 cervicovaginal fluid samples using a collection method that avoided the need for sample dilution and rigorously minimized aerobic exposure. The pH of samples was measured by microelectrode immediately after collection and under a physiological vaginal concentration of CO2. Commercial enzymatic assays of total lactate and total acetate concentrations were validated for use in CVF, and compared to the more usual HPLC method. The average pH of the CVF samples was 3.5 ± 0.3 (mean ± SD), range 2.8-4.2, and the average total lactate was 1.0% ± 0.2% w/v; this is a five-fold higher average hydrogen ion concentration (lower pH) and a fivefold higher total lactate concentration than in the prior literature. The microbicidal form of lactic acid (protonated lactic acid) was therefore eleven-fold more concentrated, and a markedly more potent microbicide, than indicated by prior research. This suggests that when lactobacilli dominate the vaginal microbiota, women have significantly more lactic acid-mediated protection against infections than currently believed. Our results invite further evaluations of the prophylactic and therapeutic actions of vaginal lactic acid, whether provided in situ by endogenous lactobacilli, by probiotic lactobacilli, or by products that reinforce vaginal lactic acid.

Indexed as

AdolescentAdultFemaleHumansHydrogen-Ion ConcentrationLactic AcidLactobacillusMicrobiotaMiddle AgedProbioticsVaginaYoung AdultLactic Acid

Identifiers

PMID24223212
PMCPMC3819307
OpenAlexW2046487574

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.